Insider · CIK 0001233539

PATTERSON LEONE D

Reports to the SEC for 10 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001233539

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37K sh	—	—	37,000
2026-06-03	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2026-01-06	ZYMEZymeworks Inc.A Award	EVP, Chief Bus & Fin Officer	AAward	+459 sh	$10.55	+$4,842.45	459
2025-06-05	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+46K sh	—	—	46,000
2025-04-10	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2025-01-10	ZYMEZymeworks Inc. · Stock Option (Right to Buy)A Award	EVP, Chief Bus & Fin Officer	AAward	+79K sh	—	—	79,000
2025-01-10	ZYMEZymeworks Inc. · Restricted Stock UnitA Award	EVP, Chief Bus & Fin Officer	AAward	+53K sh	—	—	53,000
2024-09-01	ZYMEZymeworks Inc. · Stock Option (Right to Buy)A Award	EVP, Chief Bus & Fin Officer	AAward	+360K sh	—	—	360,000
2024-06-13	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2024-02-23	TNYATenaya Therapeutics, Inc.A Award	Chief Fin. and Bus. Officer	AAward	+35K sh	—	—	95,755
2024-02-23	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Fin. and Bus. Officer	AAward	+205K sh	—	—	205,000
2024-02-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Fin. and Bus. Officer	SSale	−5,201 sh	$5.86	−$30.5K	60,755
2023-08-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Fin. and Bus. Officer	SSale	−4,452 sh	$3.81	−$17K	64,542
2023-06-07	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2023-02-15	TNYATenaya Therapeutics, Inc.A Award	Chief Fin. and Bus. Officer	AAward	+30K sh	—	—	32,000
2023-02-15	TNYATenaya Therapeutics, Inc.A Award	Chief Fin. and Bus. Officer	AAward	+35K sh	—	—	67,000
2023-02-15	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Fin. and Bus. Officer	AAward	+190K sh	—	—	190,000
2022-06-08	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-05-19	CLYMClimb Bio, Inc. · Stock Option (Right To Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-02-15	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Fin. and Bus. Officer	AAward	+66K sh	—	—	66,000
2021-06-13	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,511
2021-02-16	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	President and CFO	AAward	+240K sh	—	—	240,000
2021-02-09	Adverum Biotechnologies, Inc.S Sale	President and CFO	SSale	−12.5K sh	$14.10	−$176K	98,017
2021-02-09	Adverum Biotechnologies, Inc.S Sale	President and CFO	SSale	−62 sh	$14.14	−$876.637	97,955
2020-07-09	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.7K sh	—	—	10,700
2020-07-09	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.3K sh	—	—	18,300
2020-06-16	Adverum Biotechnologies, Inc.S Sale	President and CFO	SSale	−13.2K sh	$24.68	−$325K	110,488
2020-05-06	Adverum Biotechnologies, Inc.M Exercise/Conversion	President and CFO	MExercise/Conversion	+20K sh	$3.44	+$68.8K	143,659
2020-05-06	Adverum Biotechnologies, Inc.S Sale	President and CFO	SSale	−20K sh	$20.02	−$400K	123,659
2020-05-06	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	President and CFO	MExercise/Conversion	−20K sh	—	—	155,576
2020-03-20	Adverum Biotechnologies, Inc.M Exercise/Conversion	President and CFO	MExercise/Conversion	+24.4K sh	$3.44	+$84K	162,955
2020-03-20	Adverum Biotechnologies, Inc.S Sale	President and CFO	SSale	−39.5K sh	$10.17	−$402K	123,429
2020-03-20	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	President and CFO	MExercise/Conversion	−24.4K sh	—	—	175,576
2020-03-17	Adverum Biotechnologies, Inc.S Sale	President and CFO	SSale	−474 sh	$10.02	−$4,749.243	138,531
2020-02-20	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	President and CFO	AAward	+300K sh	—	—	300,000
2020-02-09	Adverum Biotechnologies, Inc.F Tax Payment	President and CFO	FTax Payment	−11K sh	$10.24	−$112K	139,235
2020-02-09	Adverum Biotechnologies, Inc.F Tax Payment	President and CFO	FTax Payment	−11.2K sh	$10.24	−$115K	139,005
2019-12-23	Adverum Biotechnologies, Inc.S Sale	President and CFO	SSale	−40K sh	$10.72	−$429K	150,220
2019-12-23	Adverum Biotechnologies, Inc.S Sale	President and CFO	SSale	−40K sh	$10.72	−$429K	228,496
2019-06-15	Adverum Biotechnologies, Inc.F Tax Payment	President and CFO	FTax Payment	−8,570 sh	$10.82	−$92.7K	225,502
2019-06-15	Adverum Biotechnologies, Inc.F Tax Payment	President and CFO	FTax Payment	−35.3K sh	$10.82	−$382K	190,220
2019-02-14	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	President and CFO	AAward	+800K sh	—	—	800,000
2019-02-09	Adverum Biotechnologies, Inc.F Tax Payment	President and CFO	FTax Payment	−8,176 sh	$3.33	−$27.2K	234,072
2018-10-18	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	President and CFO	AAward	+150K sh	—	—	150,000
2018-06-15	Adverum Biotechnologies, Inc.F Tax Payment	President and CFO	FTax Payment	−8,645 sh	$5.55	−$48K	242,248
2018-06-15	Adverum Biotechnologies, Inc.A Award	President and CFO	AAward	+88.5K sh	—	—	268,496
2018-02-15	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	President and CFO	AAward	+160K sh	—	—	160,000
2018-02-09	Adverum Biotechnologies, Inc.F Tax Payment	President and CFO	FTax Payment	−8,208 sh	$7.05	−$57.9K	162,397
2017-06-15	Adverum Biotechnologies, Inc.F Tax Payment	President and CFO	FTax Payment	−9,395 sh	$2.70	−$25.4K	170,605
2017-02-09	Adverum Biotechnologies, Inc.A Award	President and CFO	AAward	+80K sh	—	—	180,000

Recent filings

Accepted (ET)
Jun 114
PATTERSON LEONE D0001193125-26-267521
SEC(opens sec.gov)
Jun 44
PATTERSON LEONE D0001193125-26-257445
SEC(opens sec.gov)
Jan 74
PATTERSON LEONE D0001193125-26-006727
SEC(opens sec.gov)
Jun 94
PATTERSON LEONE D0000950170-25-083681
SEC(opens sec.gov)
Apr 114
PATTERSON LEONE D0000950170-25-053330
SEC(opens sec.gov)
Jan 104
PATTERSON LEONE D0000950170-25-004358
SEC(opens sec.gov)
Sep 34
PATTERSON LEONE D0000950170-24-102982
SEC(opens sec.gov)
Jun 144
PATTERSON LEONE D0000950170-24-073643
SEC(opens sec.gov)
Feb 274
PATTERSON LEONE D0000950170-24-021547
SEC(opens sec.gov)
Feb 164
PATTERSON LEONE D0000950170-24-016667
SEC(opens sec.gov)
Aug 184
PATTERSON LEONE D0001209191-23-046640
SEC(opens sec.gov)
Jun 94
PATTERSON LEONE D0001209191-23-035750
SEC(opens sec.gov)
Feb 174
PATTERSON LEONE D0001209191-23-010881
SEC(opens sec.gov)
Jun 104
PATTERSON LEONE D0001209191-22-035828
SEC(opens sec.gov)
Jun 14
PATTERSON LEONE D0001209191-22-033217
SEC(opens sec.gov)
Feb 174
PATTERSON LEONE D0001209191-22-010920
SEC(opens sec.gov)

Companies

Address

C/O IRULYA THERAPEUTICS INC. 101 COLLEGE STREET, SUITE 210

NEW HAVEN, CT, 06510